Obtainment of stable olive-based micro-/nano-encapsulated extracts.

Use of olive-based encapsulated ingredients.Production of innovative food products with a high health, nutritional and sensory properties. Implementation of the application of micro- and nano-encapsulation techniques in food.

Development of nanobiosensors to apply of chemical environmental stressors, functional food elements.

Use of nanobiosensors to evaluate stressors and food effects in living organism.

Diffusion to the scientific community of novel lab-on-chip platform readily adaptable to other integrated applications.

Definition of the “probiotic” status of fermented food-associated microbes.

Guide line of fermented food/diet that can improve the maintenance of human health of the application of micro- and nano-encapsulation techniques in food.

Experimental data on lipidomic profile of blood cell membrane of healthy (dog, cat and horse) vs. pathologic animals (metabolic diseases).

Identification of the relationship of lipidomic profile as prognostic factor for clinical outcome. Definition of pharmacological/dietary regimens to overcome lipidomic aberrant profiles of novel lab-on-chip platform readily adaptable to other integrated applications.

Highlight on the gut microbiome in dogs, cats vs. humans co-habitants under physiological and pathological conditions (obesity and diabetes mellitus).

Effect of diet components on microbioma of physiological obese diabetic animals.

Diet guide line for obese or diabetic pets to adjust microbial unbalance.

Acquisition of data on the relationship of genetic background, diet, life style and obesity with several dismetabolisms, including Type2 diabetes. Role of SIRT1 in the dismetabolic diseases.

Evaluation of the molecular mechanisms involved on cellular and laboratory mammals models on the exact pathways that allow SIRT1 to prevent and/or reverse obesity-induced metabolic disturbances via Resveratrol.